Literature DB >> 21184285

Familial gastric cancer: update for practice management.

Giovanni Corso1, Daniele Marrelli, Franco Roviello.   

Abstract

About 90% of gastric carcinoma presents a sporadic setting and only 10% shows a familial cluster; among this group, 1-3% are considered as hereditary syndromes, with a clear genetic pathway. The most important genetic mechanisms are associated with CDH1 germline mutations, causing the hereditary diffuse gastric cancer syndrome. Other inherited predispositions with gastric carcinoma are the hereditary nonpolyposis colorectal cancer, Li-Fraumeni and Peutz-Jeghers syndromes. In this brief update, we described these principal hereditary syndromes offering a simple management to physicians where are these diseases diagnosed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21184285     DOI: 10.1007/s10689-010-9410-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  49 in total

1.  Germline p53 mutation in a case of Li-Fraumeni syndrome presenting gastric cancer.

Authors:  K Sugano; T Taniguchi; M Saeki; Y Tsunematsu; U Tomaru; T Shimoda
Journal:  Jpn J Clin Oncol       Date:  1999-10       Impact factor: 3.019

2.  Cancer family history and genetic testing: are malpractice adjudications waiting to happen?

Authors:  Henry T Lynch
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

Review 3.  Familial gastric cancer: overview and guidelines for management.

Authors:  C Caldas; F Carneiro; H T Lynch; J Yokota; G L Wiesner; S M Powell; F R Lewis; D G Huntsman; P D Pharoah; J A Jankowski; P MacLeod; H Vogelsang; G Keller; K G Park; F M Richards; E R Maher; S A Gayther; C Oliveira; N Grehan; D Wight; R Seruca; F Roviello; B A Ponder; C E Jackson
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

4.  Absence of microsatellite instability and germline mutations of E-cadherin, APC and p53 genes in Japanese familial gastric cancer.

Authors:  M Kusano; H Kakiuchi; M Mihara; F Itoh; Y Adachi; M Ohara; M Hosokawa; K Imai
Journal:  Tumour Biol       Date:  2001 Jul-Aug

Review 5.  Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.

Authors:  Parry Guilford; Bostjan Humar; Vanessa Blair
Journal:  Gastric Cancer       Date:  2010-04-07       Impact factor: 7.370

6.  Red meat, family history, and increased risk of gastric cancer with microsatellite instability.

Authors:  D Palli; A Russo; L Ottini; G Masala; C Saieva; A Amorosi; A Cama; C D'Amico; M Falchetti; R Palmirotta; A Decarli; R Mariani Costantini; J F Fraumeni
Journal:  Cancer Res       Date:  2001-07-15       Impact factor: 12.701

7.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

Review 8.  Germline TP53 mutations and Li-Fraumeni syndrome.

Authors:  J M Varley
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

9.  Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.

Authors:  Magali Olivier; David E Goldgar; Nayanta Sodha; Hiroko Ohgaki; Paul Kleihues; Pierre Hainaut; Rosalind A Eeles
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

10.  Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.

Authors:  Rebecca C Fitzgerald; Richard Hardwick; David Huntsman; Fatima Carneiro; Parry Guilford; Vanessa Blair; Daniel C Chung; Jeff Norton; Krishnadath Ragunath; J Han Van Krieken; Sarah Dwerryhouse; Carlos Caldas
Journal:  J Med Genet       Date:  2010-07       Impact factor: 6.318

View more
  10 in total

1.  Polymorphisms of mismatch repair gene hMLH1 and hMSH2 and risk of gastric cancer in a Chinese population.

Authors:  Xian-Qiu Xiao; Wei-DA Gong; Shi-Zhi Wang; Zheng-Dong Zhang; Xiao-Ping Rui; Guo-Zhong Wu; Feng Ren
Journal:  Oncol Lett       Date:  2011-12-06       Impact factor: 2.967

2.  The identification and management of hereditary diffuse gastric cancer in a large Jordanian family.

Authors:  Henry T Lynch; Ibrahim Aldoss; Jane F Lynch
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

Review 3.  Hereditary gastrointestinal cancer.

Authors:  Keisuke Hata; Yoko Yamamoto; Tomomichi Kiyomatsu; Toshiaki Tanaka; Shinsuke Kazama; Hiroaki Nozawa; Kazushige Kawai; Junichiro Tanaka; Takeshi Nishikawa; Kensuke Otani; Koji Yasuda; Junko Kishikawa; Yuzo Nagai; Hiroyuki Anzai; Takahide Shinagawa; Keiichi Arakawa; Hironori Yamaguchi; Soichiro Ishihara; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  Surg Today       Date:  2015-12-16       Impact factor: 2.549

4.  Molecular Oncology in Management of Colorectal Cancer.

Authors:  Ramraj Nagendra Gupta Vemala; Sanjeev Vasudev Katti; Bhawna Sirohi; Divya Manikandan; Govind Nandakumar
Journal:  Indian J Surg Oncol       Date:  2021-03-16

5.  Family history of malignant neoplasm and its relation with clinicopathologic features of gastric cancer patients.

Authors:  Junxiu Yu; Bo Fu; Qi Zhao
Journal:  World J Surg Oncol       Date:  2013-08-16       Impact factor: 2.754

Review 6.  Novel Implications in Molecular Diagnosis of Lynch Syndrome.

Authors:  Raffaella Liccardo; Marina De Rosa; Paola Izzo; Francesca Duraturo
Journal:  Gastroenterol Res Pract       Date:  2017-01-29       Impact factor: 2.260

7.  History, pathogenesis, and management of familial gastric cancer: original study of John XXIII's family.

Authors:  Giovanni Corso; Fabrizio Roncalli; Daniele Marrelli; Fátima Carneiro; Franco Roviello
Journal:  Biomed Res Int       Date:  2012-12-26       Impact factor: 3.411

8.  Analysis on the clinical and pathological features and prognosis of familial gastric cancer in South china population: a single-center study of 724 patients.

Authors:  Jun Lu; Chang-Ming Huang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin
Journal:  J Oncol       Date:  2012-11-07       Impact factor: 4.375

9.  Nucleotide variants of the cancer predisposing gene CDH1 and the risk of non-syndromic cleft lip with or without cleft palate.

Authors:  Kamil K Hozyasz; Adrianna Mostowska; Piotr Wójcicki; Agnieszka Lasota; Barbara Offert; Adam Balcerek; Izabella Dunin-Wilczyńska; Paweł P Jagodziński
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

10.  Lauren classification and individualized chemotherapy in gastric cancer.

Authors:  Junli Ma; Hong Shen; Linda Kapesa; Shan Zeng
Journal:  Oncol Lett       Date:  2016-03-16       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.